The Second Quarter of 2023 the US Azithromycin Prices Online

North America

The Azithromycin Prices witnessed an upward trend in North America during the second quarter of 2023. An increment of 7.73% is seen in June compared to the levels noted in April due to an increase in demand for Azithromycin from the downstream sector and a rise in imports from China. The Manufacturing Purchasing Managers’ (PMI) Index in the US fell to 46.3 in June from the beginning of the second quarter. This indicates a contraction of production growth, leading to a high supply of Azithromycin coupled with more demand from the pharmaceuticals and nutraceuticals sectors. Apart from this, replenishment of product inventories with fresh stock in the mid of the quarter Q2 2023 has kept the market sentiments north side. Also, the decrease in inflation and energy prices has increased the consumers’ confidence leading to a gradual rise in Azithromycin prices in the second quarter. Imports prices increased in the US, demonstrating more quantity of imports of Azithromycin API from China balanced with more demand from end consumers, keeping the price on the higher side.

Asia Pacific

The price of Azithromycin rose significantly by 9.45 percent in June compared to levels observed in April. The factors responsible for this upward trend include high demand from the downstream sector amid antibiotic resistance bacteria. The CPI (Consumer Price Index) increased in May, indicating a rise in inflation in the mid of Q2 2023 that led to an increase in the prices of raw materials required in making the Azithromycin API. Apart from that, a rise in energy and oil prices has a significant role in the surging of Azithromycin prices in the domestic market as well as in foreign markets due to increased costs for businesses that rely on APIs. PMI (Purchasing Managers’ Index) of China was 49.5 in April, which increased to 50.9 in May, indicating the expansion of China’s industrial activity, along with more demand, led to a rise in the Azithromycin prices. Also, despite the ease of COVID protocols, the supply chain remains disrupted, increasing the overall transportation cost and increasing prices.


Azithromycin prices in Europe demonstrated an upward trend due to persistent demand from the downstream sector and imports from exporting countries such as China. Inflation in Germany has increased to 6.4 percent in June from May, leading to the high cost of developing and maintaining APIs. Demand for Azithromycin also increased in domestic and foreign markets, which put upward pressure on Azithromycin prices. Also, the war in Ukraine caused high energy prices in Germany that led to a rise in Azithromycin prices as the cost of production of APIs increased. The Manufacturing Purchasing Manager Index (PMI) of Germany fell to 41 in June 2023, contrasted with levels noted at the start of the second quarter. This demonstrates the contraction of production growth coupled with higher demand from the end-user sector, leading to a rise in Azithromycin prices in the market. Also, prices of Azithromycin API remained high in China in the second quarter, which made the API expensive to import in Germany.

ChemAnalyst tackles the primary difficulty areas of the worldwide chemical, petroleum, pharmaceutical, and petrochemical industries, empowering decision-makers to make informed decisions. It examines and analyses geopolitical risks, environmental concerns, raw material availability, supply chain functioning, and technological disruption. It focuses on market volatility and guarantees that clients manage obstacles and hazards effectively and efficiently. ChemAnalyst's primary expertise has been data timeliness and accuracy, benefiting both local and global industries by tuning in to real-time data points to execute multibillion-dollar projects internationally.

Showing 1 reaction

Please check your e-mail for a link to activate your account.